Financhill
Back

Evotec SE 10K Form

Sell
22

EVO
Evotec SE

Last Price:
$4.2100
Seasonality Move:
-3.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EVO News And Ratings

See the #1 stock for the next 7 days that we like better than EVO

EVO Financial Statistics

Sales & Book Value

Annual Sales: $862.6M
Cash Flow: $-56.4M
Price / Cash Flow: 0
Annual Sales: $2.78
Price / Book: 1.51

Profitability

EPS (TTM): -0.62900
Net Income (TTM): $-222.6M
Gross Margin: $124.3M
Return on Equity: -20.84%
Return on Assets: -10.26%

Evotec SE Earnings Forecast

Key Evotec SE Financial Ratios

  • The Gross Profit Margin over the past 20 years for EVO is 14.41%.
  • The Selling, General & Administrative Expenses for EVO have been equal to 23.61% of Gross Profit Margin.
  • The Research & Development expenses have been 6.38% of Revenue.
  • The Net Earning history of EVO is -24.60% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 11 years.

Evotec SE Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: EVO
Website: evotec.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 2.03
Quick Ratio: 1.77

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EVO Technical Analysis vs Fundamental Analysis

Sell
22
Evotec SE (EVO) is a Sell

Is Evotec SE a Buy or a Sell?

  • Evotec SE stock is rated a Sell
    The current Evotec SE [EVO] share price is $4.2000. The Score for EVO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.